| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
|
N Engl J Med
|
2003
|
13.99
|
|
2
|
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
|
J Natl Cancer Inst
|
2008
|
12.77
|
|
3
|
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
|
N Engl J Med
|
2007
|
5.92
|
|
4
|
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
|
J Clin Oncol
|
2012
|
3.18
|
|
5
|
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.
|
Head Neck
|
2009
|
2.59
|
|
6
|
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.36
|
|
7
|
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.
|
Head Neck
|
2012
|
2.07
|
|
8
|
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
|
Lancet Oncol
|
2007
|
2.03
|
|
9
|
Thyroid carcinoma.
|
J Natl Compr Canc Netw
|
2010
|
2.02
|
|
10
|
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.
|
Arch Otolaryngol Head Neck Surg
|
2003
|
1.76
|
|
11
|
Head and neck cancers.
|
J Natl Compr Canc Netw
|
2011
|
1.64
|
|
12
|
Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
|
Am J Clin Oncol
|
2010
|
1.52
|
|
13
|
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.
|
Oral Oncol
|
2011
|
1.45
|
|
14
|
Longitudinal predictors of continued tobacco use among patients diagnosed with cancer.
|
Ann Behav Med
|
2003
|
1.45
|
|
15
|
Correlates of tobacco use among smokers and recent quitters diagnosed with cancer.
|
Patient Educ Couns
|
2002
|
1.44
|
|
16
|
Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial.
|
J Clin Oncol
|
2010
|
1.40
|
|
17
|
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2014
|
1.39
|
|
18
|
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.
|
J Natl Compr Canc Netw
|
2013
|
1.35
|
|
19
|
A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.
|
EMBO J
|
2002
|
1.20
|
|
20
|
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients.
|
Psychooncology
|
2004
|
1.17
|
|
21
|
Thyroid carcinoma.
|
J Natl Compr Canc Netw
|
2007
|
1.13
|
|
22
|
A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients.
|
Ann Behav Med
|
2005
|
1.12
|
|
23
|
Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence.
|
Arch Otolaryngol Head Neck Surg
|
2002
|
1.06
|
|
24
|
Thyroid carcinoma.
|
J Natl Compr Canc Netw
|
2005
|
1.04
|
|
25
|
Head and neck cancers.
|
J Natl Compr Canc Netw
|
2008
|
1.01
|
|
26
|
A bupropion smoking cessation clinical trial for cancer patients.
|
Cancer Causes Control
|
2010
|
0.99
|
|
27
|
Medullary carcinoma.
|
J Natl Compr Canc Netw
|
2010
|
0.97
|
|
28
|
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
|
Head Neck
|
2012
|
0.96
|
|
29
|
The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.
|
Clin Cancer Res
|
2009
|
0.95
|
|
30
|
Intensity-modulated radiotherapy for early larynx cancer: is there a role?
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.95
|
|
31
|
Using stereolithographic models to plan mandibular reconstruction for advanced oral cavity cancer.
|
Laryngoscope
|
2007
|
0.94
|
|
32
|
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.
|
Head Neck
|
2010
|
0.94
|
|
33
|
Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies.
|
Head Neck
|
2007
|
0.94
|
|
34
|
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.
|
J Clin Oncol
|
2009
|
0.93
|
|
35
|
Head and neck sarcomas: a comprehensive cancer center experience.
|
Cancers (Basel)
|
2013
|
0.93
|
|
36
|
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
|
Thyroid
|
2013
|
0.93
|
|
37
|
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
|
Head Neck
|
2005
|
0.92
|
|
38
|
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment.
|
Head Neck
|
2004
|
0.92
|
|
39
|
Psychological functioning of caregivers for head and neck cancer patients.
|
Oral Oncol
|
2011
|
0.92
|
|
40
|
Head and neck cancers.
|
J Natl Compr Canc Netw
|
2005
|
0.91
|
|
41
|
Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
|
J Clin Oncol
|
2005
|
0.90
|
|
42
|
Mucosal melanoma of the head and neck.
|
J Natl Compr Canc Netw
|
2012
|
0.89
|
|
43
|
Informational Needs of Head and Neck Cancer Patients.
|
Health Technol (Berl)
|
2012
|
0.88
|
|
44
|
Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
|
Head Neck
|
2009
|
0.86
|
|
45
|
Surgery in the multimodality treatment of sinonasal malignancies.
|
Curr Probl Cancer
|
2010
|
0.83
|
|
46
|
p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
|
Head Neck
|
2014
|
0.83
|
|
47
|
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.
|
Clin Cancer Res
|
2013
|
0.82
|
|
48
|
Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.
|
Arch Otolaryngol Head Neck Surg
|
2009
|
0.82
|
|
49
|
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
|
Head Neck
|
2010
|
0.82
|
|
50
|
Issues related to implementing a smoking cessation clinical trial for cancer patients.
|
Cancer Causes Control
|
2008
|
0.80
|
|
51
|
Processes of change related to smoking behavior among cancer patients.
|
Cancer Pract
|
2002
|
0.79
|
|
52
|
Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
|
Cancer
|
2014
|
0.79
|
|
53
|
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
|
Curr Probl Cancer
|
2010
|
0.79
|
|
54
|
Anaplastic Thyroid Carcinoma, Version 2.2015.
|
J Natl Compr Canc Netw
|
2015
|
0.78
|
|
55
|
P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure.
|
Tumori
|
2005
|
0.78
|
|
56
|
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.78
|
|
57
|
Occult primary cancer clinical practice guidelines.
|
J Natl Compr Canc Netw
|
2005
|
0.78
|
|
58
|
Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue.
|
Oral Oncol
|
2013
|
0.77
|
|
59
|
Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.
|
Head Neck
|
2013
|
0.77
|
|
60
|
Improvement of the radial forearm flap donor defect by prelamination with human acellular dermal matrix.
|
Plast Reconstr Surg
|
2011
|
0.77
|
|
61
|
Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns.
|
Head Neck
|
2012
|
0.77
|
|
62
|
Coupling of prostate and thyroid cancer diagnoses in the United States.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
63
|
Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer.
|
Cancer
|
2013
|
0.76
|
|
64
|
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer.
|
Head Neck
|
2013
|
0.75
|
|
65
|
Treatment of head and neck cancer.
|
N Engl J Med
|
2008
|
0.75
|
|
66
|
Reply to e.g. Russi et Al and R. Haddad.
|
J Clin Oncol
|
2013
|
0.75
|
|
67
|
Methemoglobinemia: early intraoperative detection by clinical observation.
|
Laryngoscope
|
2004
|
0.75
|
|
68
|
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
|
Cancer Invest
|
2006
|
0.75
|
|
69
|
Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.
|
Ear Nose Throat J
|
2017
|
0.75
|
|
70
|
Cervical metastasis in squamous cell carcinoma of the hard palate and maxillary alveolus.
|
Ear Nose Throat J
|
2016
|
0.75
|
|
71
|
Metastatic cervical carcinoma from an unknown primary: literature review.
|
Ear Nose Throat J
|
2014
|
0.75
|
|
72
|
Asymptomatic Deep Peroneal Vein Thrombosis During Free Fibula Flap Harvest: A Review of the Literature, Strategies for Preoperative Assessment, and an Algorithm for Reconstruction.
|
Ann Plast Surg
|
2016
|
0.75
|
|
73
|
The role of neck dissection in the combined modality therapy setting.
|
Semin Oncol
|
2008
|
0.75
|